Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, December 26, 2024.
MoonLake Immunotherapeutics - Class A Ordinary Shares (NASDAQ:MLTX)
Crossroads (+60) - MLTX is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid MLTX?
MarketClub looks at technical strength and momentum to determine if the timing is right for MLTX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for MLTX
The long-term trend has been UP since Jul 16th, 2024 at 50.28
The intermediate-term trend has been DOWN since Dec 19th, 2024 at 50.60
The short-term trend has been DOWN since Dec 19th, 2024 at 51.00
Smart Scan Analysis for MLTX
Based on our trend formula, MLTX is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 52.29 | 53.41 | 52.29 | 53.41 | +0.74 |
| Prev. Close | Volume | Bid | Ask | Time |
| 52.67 | 4352 | 2024-12-26 09:37:27 |
| 52wk High | 64.98 | 52wk High Date | 2024-02-12 |
| 52wk Low | 37.55 | 52wk Low Date | 2024-06-24 |
| Average Volume | 178,963 | Shares Outstanding | 63,064 |
| Assets | 518,213,328M | Liabilities | 30,018,003M |
| P/E Ratio | -39.51610000 |